PRAX Q4 2024 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+1349.1% YoY

Gross Profit

-$49M-654.2% margin

Operating Income

-$64M-857.0% margin

Net Income

-$59M-786.3% margin

EPS (Diluted)

$-2.94

QoQ Revenue Growth

+2371.2%

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$56M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$483M

Total Liabilities

$38M

Stockholders' Equity

$445M

Cash & Equivalents

$215M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$515,000	+1349.1%
Gross Profit	-$49M	-$18M	-173.2%
Operating Income	-$64M	-$28M	-130.0%
Net Income	-$59M	-$27M	-118.3%

Revenue Segments

Option Exercise Fee

$6M100%